¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31
±³À°ÀÏÀÚ : 2024-05-31
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø ¿¬±¸°ü

±³À°ÁÖÁ¦ : 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸

´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581

À̸ÞÀÏ : hematology@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í ºñȸ¿ø 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 13:30~14:00 Clinical significance of BRAFV600E-positive cells as measurable residual disease (MRD) in Langerhans cell histiocytosi Ko Kudo(Hirosaki University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:00~14:30 How we treat LCH(Langerhans cell histiocytosis) in Taiwan Grace Yu Mei Liao(Medical University, Taiwan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 14:30~15:00 Unraveling the Genetic Tapestry of Langerhans Cell Histiocytosis in Korean Patients °í°æ³²(¿ï»êÀÇ´ë)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:15~15:45 Stratified treatment of pediatric HLH(Hemophagocytic lymphohistiocytosis) Rui Zhang(Capital  Medical University, China)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 15:45~16:15 Primary and secondary hemophagocytic lymphohistiocytosis in Japan Shouichi Ohga(Kyushu University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 16:15~16:45 HLH(Hemophagocytic lymphohistiocytosis) in Korea ÃÖÁ¤À±(¼­¿ïÀÇ´ë )

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:00~17:30 CAR-T related CSS & cytopenia Yoshiyuki Takahashi(Nagoya University, Japan)

±³À°½Ã°£ 05¿ù 31ÀÏ °­ÀǽÇ1 17:30~18:00 CAR-T related HLH(Hemophagocytic lymphohistiocytosis) À¯Àç¿ø(°¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀ忬±¸ÇÐȸ ºÎ¿ï°æÁöȸ Á¤±âÁý´ãȸ : 2024-04-29
´ÙÀ½±Û ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
948 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø µ¿¹® Áö¿ªÀÇ»ç Áý´ãȸ : 2018-10-16 0 617 2018-09-19
947 ¼­¿ï ¼øõÇâÀÇ´ë ¼­¿ïº´¿ø Á¦263ȸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2018-10-15 0 1,159 2018-09-19
946 ¼­¿ï °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø 2018³âµµ Á¦4ȸ ±âħ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-10-14 0 625 2018-09-19
945 ºÎ»ê 2018 ºÎ»ê¿ï»ê°æ³²Ä¡¸ÅÇÐȸ Ã߰躸¼ö±³À° (Motor symptoms of dementia) : 2018-10-13 0 912 2018-09-19
944 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-10-13 0 963 2018-09-19
943 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Yonsei Lung Transplant Academy 2018 : 2018-10-13 0 812 2018-09-19
942 °æ³² â¿ø°æ»ó´ëº´¿ø Á¦3ȸ ´ëÇÑ°ß¡¤ÁÖ°üÀýÇÐȸ °æ»óÁöȸ Çмú´ëȸ : 2018-10-13 0 1,234 2018-09-19
941 ´ë±¸ °æºÏ´ëº´¿ø ´ëÇÑÇǺΰúÇÐȸ 2018³â Á¦2Â÷ ¸ð¹ß¿¬¼ö±³À° (ÁÖÁ¦: Å»¸ðÁõÀÇ Áø´Ü°ú Ä¡·á) : 2018-10-13 1 1,618 2018-09-19
940 ¼­¿ï 2018 ´ëÇѳúÀüÁõÇÐȸ 10¿ù º¸¼ö±³À°(Basics and updates in Epilepsy) : 2018-10-13 0 656 2018-09-19
939 Á¦ÁÖ Á¦ÁÖ´ëÇб³º´¿ø Á¦7ȸ ÇǺΰú Á¦ÁÖÁöºÎȸ ÇмúÁý´ãȸ : 2018-10-12 0 897 2018-09-19
938 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ Ãß°èÇмú´ëȸ : 2018-10-12 1 1,729 2018-09-19
937 ¼­¿ï ´ëÇÑÀÓ»óÈ­ÇÐȸ 2018³â Ãß°èÇмú´ëȸ : 2018-10-12 0 783 2018-09-19
936 ¼­¿ï »õ·Î¿î ¾ÏÄ¡·áÀÇ ½Ã´ë°¡ ¿­¸®´Ù : 2018-10-10 0 1,094 2018-09-19
935 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ³»°ú °­»ç ¹× Àü°øÀÇ¿Í °³¿øÀǸ¦ À§ÇÑ Æ¯°­ : 2018-10-10 0 1,134 2018-09-19
934 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ 17th KSGE EUS Hands-on Workshop & EUS Summit 2018 & WISE 2018 (Module III) : 2018-10-07 0 1,169 2018-09-19
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷